When should 5% dextrose in water (D5W) be used instead of 5% dextrose in normal saline (D5NS) for intravenous fluid therapy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 6, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

When to Use Dextrose in Water vs. Dextrose in Normal Saline

For volume resuscitation and maintenance fluid therapy in acutely ill patients, normal saline (without dextrose) should be used first-line, while D5W is reserved for specific situations including epinephrine infusions, free water replacement in hypernatremia, and once glucose drops below 250 mg/dL during DKA treatment.

Volume Resuscitation and Initial Fluid Therapy

Use Normal Saline (0.9% NaCl) - NOT dextrose solutions:

  • Anaphylaxis and shock states: Normal saline is the fluid of choice because dextrose is rapidly extravasated from the intravascular circulation to the interstitial tissues 1. In anaphylaxis, increased vascular permeability can permit transfer of 50% of intravascular fluid into the extravascular space within 10 minutes, making dextrose-containing solutions ineffective for volume expansion 1.

  • Acute volume resuscitation: For any patient requiring rapid fluid boluses (e.g., 5-10 mL/kg in first 5 minutes for adults, up to 30 mL/kg in first hour for children), isotonic saline without dextrose is indicated 1.

Maintenance Intravenous Fluids

Use isotonic fluids (0.9% NaCl or balanced crystalloids) - NOT hypotonic dextrose solutions:

  • Acutely ill children (28 days to 18 years): Isotonic fluids should be administered to prevent hospital-acquired hyponatremia 2. This is a strong recommendation with Grade A evidence based on multiple clinical trials showing reduced hyponatremia risk without increased hypernatremia, fluid overload, or hyperchloremic acidosis 2.

  • The historical practice of using hypotonic fluids (like D5W or D5 0.45% NaCl) has been associated with deaths from severe hyponatremia 2.

Specific Indications for D5W (Dextrose in Water)

Use D5W in these specific scenarios:

1. Epinephrine Infusions

  • When preparing continuous epinephrine infusions for refractory anaphylaxis: add 1 mg epinephrine to 250 mL of D5W 1. This is the standard diluent recommended in guidelines.

2. Diabetic Ketoacidosis (DKA) - After Initial Resuscitation

  • Initial phase: Use 0.9% NaCl for volume expansion 3.
  • Transition phase: Once serum glucose reaches 250 mg/dL, switch to 5% dextrose with 0.45-0.75% NaCl (D5 0.45% NS or D5 0.75% NS) with appropriate potassium supplementation 3.
  • In pediatric adrenal insufficiency with DKA, consider D5NS or D10NS during the first hour 4.

3. Free Water Replacement in Hypernatremia

  • Nephrogenic diabetes insipidus (NDI): D5W matches the hypotonic urinary losses (very low sodium concentration) and provides appropriate free water replacement 5.
  • Critical caveat: D5W should NOT be administered as a bolus due to risk of rapid sodium decrease and cerebral edema 5. It should be given as a controlled infusion.
  • Isotonic fluids are only appropriate for acute hypovolemic shock (rare in NDI), followed by sufficient free water provision 5.

4. Hypoglycemia Treatment

  • For acute hypoglycemia: D10W at 200 mg/kg (2 mL/kg) for infants and young children 4.
  • D25W or D50W can be used in older children/adults but D50W is irritating to veins and dilution to 25% is desirable 4.
  • Continuous infusion: D10W-containing IV fluids at 100 mL/kg per 24 hours (7 mg/kg per minute), titrated to normoglycemia 4.

Specific Indications for D5NS (Dextrose in Normal Saline)

Use D5NS when:

1. DKA Glucose Management

  • Once glucose reaches 250 mg/dL during DKA treatment, transition to D5 with 0.45-0.75% NaCl 3.

2. Medication Dilution

  • Ranitidine can be diluted in D5W for IV administration 1.

3. Pediatric Adrenal Crisis

  • Consider D5NS or D10NS bolus (20 mL/kg) during first hour of treatment 4.

Critical Pitfalls to Avoid

  1. Never use D5W for volume resuscitation: It extravasates rapidly and is ineffective for intravascular volume expansion 1.

  2. Avoid hypotonic maintenance fluids in acutely ill children: Multiple deaths have been reported from hospital-acquired hyponatremia 2.

  3. Monitor sodium correction carefully: When using D5W for hypernatremia, ensure sodium decrease does not exceed 8 mEq/day to prevent osmotic demyelination 6.

  4. Maternal-fetal considerations: Large dextrose loads (>25g) before cesarean section cause fetal hyperglycemia, hyperinsulinemia, neonatal hypoglycemia, and increased jaundice 7. Limit to <6 g/hour if needed.

  5. Blood product incompatibility: D5W causes hemolysis and clumping when mixed with red blood cells 8. Never use the same IV line.

  6. Drug diluent effects: Using saline instead of D5W as a drug diluent increases risk of hypernatremia and hyperchloremia, though without affecting mortality 9.

Algorithm for Fluid Selection

Step 1: Is this volume resuscitation/shock?

  • Yes → Normal saline (no dextrose)
  • No → Proceed to Step 2

Step 2: Is this maintenance fluid therapy?

  • Yes → Isotonic saline or balanced crystalloid (no dextrose initially) 2
  • No → Proceed to Step 3

Step 3: Check specific indication:

  • Epinephrine infusion → D5W
  • DKA with glucose >250 mg/dL → Normal saline
  • DKA with glucose <250 mg/dL → D5 0.45-0.75% NaCl
  • Hypernatremia/NDI → D5W (controlled infusion)
  • Hypoglycemia → D10W, D25W, or D50W
  • Adrenal crisis → Consider D5NS or D10NS

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.